This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 4ce58073-d13f-4cf9-a3c4-5e7590a0
Millions of older Americans with obesity could potentially get Medicare’s help with the hefty price of a weight-loss medication in order to reduce their high risk of heart problems. But
New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in
Credit: Unsplash/CC0 Public Domain Using artificial intelligence (AI) to aid clinical decision making in identifying and managing myocardial infarction (MI; heart attack) in patients presenting to the emergency department (ED)
